表皮调节素
摘要
表皮调节素是表皮生长因子家族的新成员 ,是从鼠成纤维细胞来源的肿瘤细胞系N2H3T3/T7的条件培养基中纯化出来的。表皮调节素在各种上皮细胞来源的正常组织及肿瘤组织中发挥了一定的作用 ,通过对其表达。
出处
《国外医学（皮肤性病学分册）》
2004年第2期108-110,共3页
Foreign Medical Sciences(Section of Dermatology and Venereology)
参考文献40
-
1Toyoda H,Komurasaki T,Uchida D,et al.Epiregulin.A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes.J Biol Chem,1995,270(13):7495—7500.
-
2Toyoda H,Komurasaki T,Uchida D,et al.Distribution of mRNA for human epiregulin,a differentially expressed member of the epidemlal growth factor family.Biochem J,1997,326(Pt l):69—75.
-
3Torring N,Jorgensen PE,Sorensen BS,et al.Increased expression of heparin bindi“g EGF(HB—EGF),amphiregulin,TGF alpha and epiregulin in androgen—independent prostate cancer cell lines.Anticancer Res,2000,20(1A):91—95.
-
4Zhu Z,KIeeff J,Friess H,et al.Epiregulin is Up.regulated i“pancreatic cancer and stimulates pancreatic cancer cell growth.Biochem Biophys Res Commun,2000,273(3):1019—1024.
-
5Baba I,Shirasawa S,1wam。to R,et al.Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells.Cancer Res.2000.60.(24):6886—6889.
-
6Thogersen VB,Sorensen BS。Poulsen SS.et al.A subclass of HERI ligands are prognostic markers for survival in bladder cancer patients.Cancer Res,2001,6l(16):6227—6233.
-
7Das SK,Das N,Wang J,et al.Expression of betacellulin and epiregulin genes in the mouse uterus temporally by the blastocyst solely at the site of“s apposition is coincident with the’’window”of implantation.Dev Biol,1997,190(2):178—190.
-
8Yamanaka Y,Hayashi K.Komurasaki T.et al.EGF family ligand—dependent phenotypic modulation of smooth muscle cells through EGFreceptor.Biochem Biophys Res Commun,2001.28l(2):373—377.
-
9Komurasaki T,Toyoda H,Uchida D.et al.Mechanism of growth prorooting activity of epiregulin in primary cultures of rat hepatocytes.Growth Factors,2002,20(2):61—69.
-
10Mishra R,Leahy P,Simonson MS.Gene expression profiling reveals role for EGF—family ligands in mesangial cell proliferation.Am J Physiol Renal Physiol,2002,283(5):F1151—1159.
-
1于肯明.受体活化后的钙内流[J].大同医专学报,1994,14(2):74-75.
-
2毛光美.阿司匹林临床新用及其配伍[J].实用医技杂志,2004,11(08A):1493-1494.
-
3刘征.口服抗糖尿病药物开发应用新进展[J].黑龙江医药,2005,18(4):289-290.
-
4于康.饮食禁忌辨析[J].家庭健康（医学科普）,2005(9):27-28.
-
5金伟秋（摘）.药物研究开发、生产及销售——2004年美国的IND创新记录[J].国外药讯,2006(1):46-46.
-
6嵇波,宋晓东,刘剑刚,史大卓,王永炎.氧化低密度脂蛋白诱导血管内皮细胞损伤的条件培养基对血管平滑肌细胞增殖的作用[J].中国分子心脏病学杂志,2004,4(5):279-283. 被引量：4
-
7陈清山,王桂松.与阿片类药物成瘾相关的神经递质及受体[J].立体定向和功能性神经外科杂志,2008,21(6):370-372. 被引量：2
-
8李智,解华,田月洁.基因多态性与氯吡格雷的合理用药[J].中国药师,2010,13(12):1729-1733. 被引量：7
-
9陆祖谦.双胍类降糖药物对2型糖尿病治疗价值的重新认识[J].临床药物治疗杂志,2010,8(4):33-38. 被引量：32
-
10胡怀玉,孟春英.老年糖尿病患者用药依从性调查分析[J].中国护理管理,2009,9(7):27-29. 被引量：33
